Novel anticancer alkyl pyridinium derivative exhibits antiproliferative activity via G0/G1 cell cycle arrest and apoptosis activation in triple-negative breast cancer cells
{{output}}
Triple-negative breast cancer (TNBC) remains one of the most aggressive and treatment-resistant subtypes of breast cancer, urgently demanding novel therapeutic strategies. In this study, we report the synthesis, structure, physicochemical characterization, and... ...
